Just a few days have passed since decade-long economic sanctions on Iran were lifted, as the middle-eastern powerhouse agreed to curb the progress of its controversial nuclear programme. But the race for the pharmaceutical industry to make the most of the situation is already on.(...)
There is still a climate of distrust between the country and the western world, and building that trust is a journey that could face setbacks and see certain parts of the sanctions re-imposed at any time. Pharma companies may also still be put off by the extremely strong generics market Iran has been forced to develop to be self-sufficient for the past decade. However, it is a far more attractive place to sell drugs today than this time last year.
(Más)
Entradas
No hay comentarios:
Publicar un comentario